Alkeran Tablets (Melphalan): Uses, Side Effects & Warnings

• Alkeran Tablets (Melphalan) is an alkylating chemotherapy agent primarily used to treat multiple myeloma and ovarian cancer.
• It works by damaging the DNA of cancer cells, preventing their growth and division.
• Strict adherence to prescribed dosage and administration instructions, often on an empty stomach, is crucial for effectiveness and safety.
• Common side effects include bone marrow suppression, nausea, vomiting, and hair loss; serious side effects like severe infections or secondary cancers require immediate medical attention.
• Important warnings include risks of severe bone marrow suppression, secondary malignancies, and potential harm to a fetus during pregnancy.

Uses and Indications of Alkeran Tablets (Melphalan)

Alkeran Tablets (Melphalan) is an antineoplastic agent belonging to the class of alkylating drugs, which are designed to disrupt the DNA of rapidly dividing cells, including cancer cells. The primary mechanism involves the formation of cross-links in DNA strands, preventing cell replication and leading to cell death. This targeted action makes it an effective treatment option for specific malignancies.

The main Alkeran uses and indications include the treatment of multiple myeloma and ovarian cancer. In multiple myeloma, a cancer of plasma cells, Melphalan is often used alone or in combination with other drugs, particularly in high-dose regimens with autologous stem cell transplantation. For ovarian cancer, it may be used as palliative treatment when other therapies have failed or are not appropriate. These uses of Melphalan in cancer underscore its role in managing advanced or refractory diseases.

Multiple Myeloma Treatment

For patients with multiple myeloma, Melphalan has been a cornerstone of therapy for decades. It is particularly effective in conditioning regimens prior to high-dose chemotherapy and stem cell rescue, significantly improving response rates and progression-free survival. The drug’s ability to reduce the burden of cancerous plasma cells makes it invaluable in achieving deep remissions. According to the American Cancer Society, multiple myeloma accounts for about 1.8% of all new cancer cases in the United States, highlighting the importance of effective treatments like Melphalan.

Ovarian Cancer Management

In the context of ovarian cancer, Melphalan is typically reserved for advanced stages, often after initial treatments have been unsuccessful. It can provide a therapeutic option for patients with recurrent or persistent disease, helping to control tumor growth and manage symptoms. While not a first-line therapy, its inclusion in treatment protocols for certain patient populations demonstrates its continued relevance in the oncology landscape. The National Cancer Institute estimates that ovarian cancer is the fifth leading cause of cancer-related deaths among women, emphasizing the need for diverse treatment options.

How to Take Alkeran Tablets and Dosage

Proper administration of Alkeran Tablets (Melphalan) is critical to maximize its therapeutic effect and minimize potential risks. Patients must strictly follow the instructions provided by their healthcare provider. Generally, how to take Alkeran tablets involves oral administration, typically on an empty stomach, at least one hour before or two hours after a meal, to ensure optimal absorption. It is usually taken once daily, but the exact schedule and duration will vary based on the specific cancer being treated, the patient’s overall health, and their response to therapy.

The Melphalan dosage information is highly individualized. It is determined by factors such as the patient’s body surface area, kidney function, and bone marrow reserve. Dosages are often adjusted based on regular blood tests that monitor blood cell counts, as Melphalan can significantly suppress bone marrow activity. It is crucial not to crush, chew, or break the tablets. If a dose is missed, patients should contact their doctor for advice rather than taking a double dose. Always store the medication at room temperature, away from moisture and heat, and out of reach of children.

Melphalan Tablet Side Effects

Like all chemotherapy agents, Melphalan tablet side effects can range from common and manageable to severe and life-threatening. The most significant and common adverse effect is bone marrow suppression, which can lead to a reduction in white blood cells (increasing infection risk), red blood cells (anemia, causing fatigue), and platelets (thrombocytopenia, leading to bleeding or bruising). Regular blood tests are essential to monitor these changes.

Other common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and mouth sores (mucositis). Hair loss (alopecia) is also a frequent occurrence. More serious, though less common, side effects can include liver problems, allergic reactions, and the development of secondary malignancies, particularly acute myeloid leukemia, which can occur several years after treatment. Patients should report any unusual or severe symptoms to their healthcare provider immediately.

Common side effects of Melphalan include:

• Nausea and vomiting
• Diarrhea
• Mouth sores (mucositis)
• Hair loss (alopecia)
• Fatigue and weakness
• Skin rash or itching
• Temporary or permanent infertility

It is important to note that not everyone experiences these side effects, and their severity can vary greatly among individuals. Supportive care, such as anti-nausea medications, can help manage some of these symptoms.

Alkeran (Melphalan) Warnings and Precautions

Several critical Alkeran warnings and precautions must be considered before and during treatment with Alkeran Tablets (Melphalan). The most significant concern is severe bone marrow suppression, which can be life-threatening. This necessitates frequent monitoring of complete blood counts (CBCs) throughout therapy. Dose adjustments or temporary discontinuation of the drug may be required based on these blood test results to prevent severe complications like overwhelming infections or hemorrhage.

Another serious warning involves the risk of secondary malignancies. Patients treated with alkylating agents like Melphalan have an increased risk of developing secondary cancers, particularly acute leukemia, several years after initial treatment. This risk is dose-dependent and cumulative. Furthermore, Melphalan can cause significant harm to a fetus, making it contraindicated during pregnancy. Women of childbearing potential and men should use effective contraception during and for a period after treatment. Breastfeeding is also not recommended due to the potential for serious adverse reactions in the infant. Patients with impaired renal function may require dose adjustments, as Melphalan is primarily excreted by the kidneys, and accumulation can increase toxicity. Patients should inform their doctor about all other medications they are taking, including over-the-counter drugs, supplements, and herbal remedies, to avoid potential drug interactions.

Frequently Asked Questions

What is Alkeran Tablets (Melphalan) used for?

Alkeran Tablets (Melphalan) is a chemotherapy drug primarily indicated for the treatment of multiple myeloma, a cancer of plasma cells, and advanced ovarian cancer. It works by damaging the DNA of cancer cells, preventing them from growing and multiplying. It may be used alone or in combination with other treatments, often as part of high-dose regimens before stem cell transplantation for multiple myeloma. Its application depends on the specific cancer type, stage, and individual patient factors.

What are the most common side effects of Melphalan?

The most common side effects of Melphalan include bone marrow suppression, leading to low white blood cell counts (increasing infection risk), low red blood cell counts (anemia), and low platelet counts (bleeding risk). Other frequent side effects are gastrointestinal issues such as nausea, vomiting, diarrhea, and mouth sores. Hair loss and fatigue are also commonly reported. Patients should discuss any side effects with their healthcare provider for appropriate management.

How should Alkeran Tablets be stored?

Alkeran Tablets should be stored at room temperature, ideally between 20°C to 25°C (68°F to 77°F), away from moisture and direct light. It is crucial to keep the medication in its original, tightly closed container and out of the reach of children and pets. Do not store it in the bathroom or near a sink. Always check the expiration date and dispose of any expired medication safely according to local guidelines or by returning it to a pharmacy.